Search
solithromycin (Solitaire)
Indications:
- monotherapy for community-acquired pneumonia*
* non-inferior to moxifloxacin [1]
Dosage:
- 800 mg on day 1, 400 mg on days 2-5
Adverse effects:
- diarrhea 4%
- nausea/vomiting 2-4%
- headache 4%
- dizziness 2%
Interactions
drug adverse effects of macrolide(s)
General
macrolide (macrolide antibiotic)
References
- Barrera CM, Mykietiuk A, Metev H et al
Efficacy and safety of oral solithromycin versus oral
moxifloxacin for treatment of community-acquired bacterial
pneumonia: a global, double-blind, multicentre, randomised,
active-controlled, non-inferiority trial (SOLITAIRE-ORAL).
Lancet Infectious Diseases. Feb 4, 2015
PMID: 26852726
http://thelancet.com/journals/laninf/article/PIIS1473-3099%2816%2900017-7/abstract